Amino Acids

Overview

Amino acids are organic compounds that serve as the fundamental building blocks of proteins and play indispensable roles across virtually every biological process. Structurally, each amino acid contains a central carbon atom bearing an amino group (–NH₂), a carboxyl group (–COOH), a hydrogen atom, and a distinctive side chain (R group) that determines its chemical identity and functional properties. Of the approximately 500 naturally occurring amino acids, 20 are genetically encoded and used in ribosomal protein synthesis, of which 9 are considered essential in humans — meaning they cannot be endogenously synthesized and must be obtained through diet. Beyond their structural roles in proteins, amino acids function as metabolic intermediates, neurotransmitter precursors, signaling molecules, and regulators of gene expression. Notable examples include glycine and glutamic acid, which act as inhibitory and excitatory neurotransmitters respectively in the central nervous system, and arginine, which serves as a precursor to nitric oxide, a critical vasodilatory and immune-modulatory signaling molecule.

The biochemical versatility of amino acids extends into pharmacology, food science, diagnostics, and biotechnology. Individual amino acids such as tryptophan, leucine, tyrosine, proline, valine, isoleucine, and methionine are substrates for dedicated membrane transporters — including L-type amino acid transporter 1 (LAT1) and the neutral amino acid transporter SLC6A15 (B0AT2) — that regulate their distribution across tissues including the blood-brain barrier. Dysregulation of amino acid metabolism has been implicated in conditions ranging from preeclampsia and type 2 diabetes to metabolic dysfunction-associated steatotic liver disease and diabetic nephropathy, positioning amino acids as both biomarkers of disease and therapeutic targets.

Focus of Latest Publications

Recent publications on amino acids have focused on their roles as metabolic mediators, therapeutic adjuncts, analytical interferents, and biomarkers across diverse biomedical contexts. Several studies examined glycine, alone or in combination with other agents, in experimental diabetes and diabetic complications. In streptozotocin-induced diabetic rats, glycine combined with N-acetylcysteine produced the strongest renoprotective effect, improving oxidative stress markers and preserving renal histology more effectively than either treatment alone, with earlier intervention showing greater benefit. In a separate diabetic rat study, glycine combined with thymoquinone reduced fasting blood glucose, oxidative stress, and inflammation, improved metabolic dysfunction, and provided pancreatic cytoprotection, again outperforming single-agent treatment.

Amino acids were also investigated as potential disease-associated biomarkers and mechanistic contributors in metabolic and vascular disorders. One publication proposed that maternal dietary and serum amino acid levels may be risk factors for preeclampsia and could help identify specific amino acids as biomarkers for novel dietary intervention strategies. Another study linked gut microbiota-associated leucine elevation to cold-induced atherosclerotic plaque formation and instability, highlighting amino acid metabolism as a possible mediator of environmental stress-related vascular pathology. In metabolic liver disease, plasma amino acids were evaluated alongside tricarboxylic acid cycle intermediates and acylcarnitines in metabolic dysfunction-associated steatotic liver disease, particularly in advanced fibrosis without type 2 diabetes, reflecting continued interest in amino acid profiles as indicators of altered energy metabolism.

Beyond disease biology, amino acids were studied in transporter biology, analytical chemistry, and food science. SLC6A15 (B0AT2), a sodium-dependent neutral amino acid transporter, was presented as a therapeutic target in neuropsychiatric disorders, with a dual-platform screening strategy developed to accelerate discovery of modulators. In biotherapeutic analysis, amino acids used as formulation excipients were shown to affect imaged capillary isoelectric focusing behavior depending on their pI relative to the analyte, with some causing gradient distortion and concentration-dependent pI shifts. Additional studies characterized amino acid profiles in Zanthoxylum bungeanum sprouts and Antarctic krill hydrolysate, demonstrating their utility in nutritional quality assessment and flavor enhancement, respectively.

Key Publications

• NEWJun Gut microbiota-associated leucine elevation promotes cold-induced atherosclerotic plaque formation and instability. (Journal of translational medicine, 2026, PMID 42321866): "Gut microbiota-associated leucine elevation promotes cold-induced atherosclerotic plaque formation and instability."
• Jul In Vivo Metabolic Profiling of Equisetum debile Roxb. in Rats Based on High-Resolution Mass Spectrometry. (Biomedical chromatography : BMC, 2026, PMID 42237494): "E. debile was found to contain abundant organic acids, flavonoids, amino acids, and glycosides."
• Jun Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N-Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy. (Pharmacology research & perspectives, 2026, PMID 42220095): "This study investigated the renoprotective effects of glycine (GLY), N-acetylcysteine (NAC), and their combination administered at early versus late stages of streptozotocin induced diabetes."
• May Combining glycine with thymoquinone offers a promising strategy for diabetes treatment. (Scientific reports, 2026, PMID 42156484): "Researchers are exploring safer, natural alternatives as thymoquinone and glycine."
• May Amino acids: Missing link in preeclampsia pathogenesis? (European journal of nutrition, 2026, PMID 42133093): "This study was designed to determine maternal dietary and serum amino acid (AA) levels as risk factors for preeclampsia (PE), aiming to identify the potential of specific AAs as biomarkers that could lead to novel dietary intervention strategies."
• May Unlocking SLC6A15 (B0AT2): A Dual-Platform Approach To Accelerate Drug Discovery for Neuropsychiatric Disorders. (Analytical chemistry, 2026, PMID 42118683): "SLC6A15 is a transmembrane protein that facilitates the symport of neutral and branched-chain amino acids, particularly proline, leucine, isoleucine, valine, and methionine, with sodium ions."
• May Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D). (Metabolomics : Official journal of the Metabolomic Society, 2026, PMID 42096005): "Amino acids (AAs), tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines (ACs) can reflect energetic metabolism."
• May Impact of Amino Acid Excipients on icIEF Method Development in Protein Therapeutics: A Formulation-Aware Analytical Framework. (AAPS PharmSciTech, 2026, PMID 42091782): "Although amino acids are widely used as formulation excipients for physicochemical stabilization, their potential to interfere with icIEF analyses has not been systematically evaluated."
• Jun Evaluation of Zanthoxylum bungeanum sprouts amino acids profile by capillary electrophoresis and principal component analysis. (Food chemistry, 2026, PMID 41956053): "The content of the amino acids in ZBS ranged from 1.57 to 12.82 mg/g, in which the glycine content occupied about 50%."
• May Exploring aroma descriptions of different cherry juice and the mechanism of aroma formation in Lapins using volatilomics and machine learning. (Food chemistry, 2026, PMID 41861739): "The mechanism of aroma formation was analyzed, which involved the metabolism of pyruvic acid, amino acids, fatty acids and carotenoids."